Pharmaceuticals news FT.com

Hims & Hers looks to offer replica obesity drugs in UK and Europe

US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava

Jun 3, 2025 - 12:20
 0
Hims & Hers looks to offer replica obesity drugs in UK and Europe
US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava
Read More

Tags:

Previous Article

ASCO: OSE shares 65% overall survival rate behind therapeutic cancer vaccine's p...

Next Article

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Da...

Related Posts

Novo Nordisk ousts boss as Ozempic maker battles slump

Novo Nordisk ousts boss as Ozempic maker battles slump

May 16, 2025  0

Trump’s drug price treatment is harsh but justified

Trump’s drug price treatment is harsh but justified

May 13, 2025  0

Fund for struggling biotechs takes aim at ‘tragedy’ for shareholders

Fund for struggling biotechs takes aim at ‘tragedy’ for...

May 12, 2025  0